Abstract: The present invention relates to the compound of formula (I): or a pharmaceutically acceptable salt or an in vivo hydrolysable ester thereof. This compound of formula (I) is conveniently called: (E)-7[4-(4-fluorophenyl)-6-isopropyl-2-mesylaminopyrimidin-5-yl]-(3R,5S)-dihydroxyhept-6-enoic acid.

Abstract: The present invention relates to the use of an angiotensin II receptor antagonist in the manufacture of a medicament for improving cognitive function.

Abstract: The present invention relates to the use of an angiotensin II receptor antagonist in the manufacture of a medicament for the prevention of atheroma progression and the regression of atheroma.

Abstract: Detection systems for mass spectrometry involving a combination of novel detector face coatings, repeller grid position and voltage, and in some embodiments employing tandem detectors, an interplate voltage. The mass spectra show improved sensitivities to high mass ions.

Abstract: The present invention relates to the use of an angiotensin II receptor antagonist in the manufacture of a medicament for improving cognitive function.

Abstract: A satellite crash sensor for use in a noisy area such as a crush zone has a crash dependent clock that uses an accumulated velocity signal derived from the acceleration signal, rather than the acceleration signal itself, to determine initiation and counting of the clock count. Successive velocity values are accumulated in an accumulated velocity value that is limited between zero and a maximum limit value. The clock count is incremented away from an initial zero value when the accumulated velocity value is greater than zero and back toward the zero value when the accumulated velocity value is equal to zero. The clock count is used as a measure of time from initiation of a possible crash event in the generation of a restraint deploy indicating signal in the satellite crash sensor.

Abstract: The present invention relates to the use of an angiotensin II receptor antagonist in the manufacture of a medicament for primary and secondary prevention of infarction.

Abstract: The present invention relates to the use of an angiotensin II receptor antagonist in the manufacture of a medicament for the treatment of hemorrhagic stroke.

Abstract: The present invention relates to the use of an angiotensin II receptor antagonist in the manufacture of a medicament for the prevention of atheroma progression and the regression of atheroma.

Abstract: Described is a water-absorbent composition containing from 30 to 100% by weight, based on the water-absorbent composition, of water-insoluble water-swellable hydrogels characterized by the following features:

Abstract: The present invention relates to the use of an angiotensin II receptor antagonist in the manufacture of a medicament for primary and secondary prevention of infarction.

Abstract: The present invention relates to the use of an angiotensin II receptor antagonist in the manufacture of a medicament for the treatment of angina.

Abstract: A vehicle satellite crash sensor includes a microcomputer with a stored datum indicating intended use in a frontal application such as the front crush space or a side application such as a vehicle side door. The microcomputer also stores a program that processes a sensed acceleration signal, derives an oscillation value and derives an occupant restraint deployment signal at least in response to the oscillation value. The program includes stored code for two alternative oscillation derivation algorithms: one of which is used in frontal applications and derives an integral of the absolute value of the sensed acceleration signal; the other of which is used in side applications and derives an integral of the sensed acceleration. The stored datum determines which of the stored oscillation algorithms is used.

Abstract: Described are water-insoluble water-swellable hydrogels which have been coated with steric or electrostatic spacers and which have the following pre-coating features:

Abstract: The present invention relates to the use of an angiotensin II receptor antagonist in the manufacture of a medicament for the treatment of diabetic retinopathy.

Abstract: A multi-purpose graphics display enclosure assembly comprised of a transparent shield, a decor insert or inserts, a backer plate therefor, and a frame configured to perimeter-retain the above against and removably snap over the perimeter of a base plate which is removably attached to a functional or decorative artifact by one of a variety of means that are concealed in or behind the assembled enclosure, said assembly planar surfaces of shield, decor, decor backer plate and base plate having aligned apertures for electric switches and/or receptacles or communication line outlets or the like, said base plate having additional apertures for detachable attachment fasteners with which to secure said base plate to any one of a variety of artifacts or surfaces.

Abstract: A template to guide wallcovering applicators, be they professional or amateur, in the matching and cutting of any patterned wallcovering used to cover electrical switch and/or receptacle plates with the same patterned wallcovering applied to the wall contiguous to said wall plates.

Abstract: The present invention relates to the use of an angiotensin II receptor antagonist in the manufacture of a medicament for the treatment of haemorrhagic stroke.

Abstract: The present invention relates to the use of an angiotensin II receptor antagonist in the manufacture of a medicament for primary and secondary prevention of infarction.

Abstract: The resent invention relates to the use of an angiotensin II receptor antagonist in the manufacture of a medicament for the treatment of angina.